Total Payments
$525,489
2024 Payments
$104,352
Companies
28
Transactions
804
Medicare Patients
1,288
Medicare Billing
$533,232
Payment Breakdown by Category
Other$409,627 (78.0%)
Travel$74,561 (14.2%)
Food & Beverage$23,259 (4.4%)
Consulting$17,845 (3.4%)
Education$197.56 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250,964 | 147 | 47.8% |
| Honoraria | $158,663 | 93 | 30.2% |
| Travel and Lodging | $74,561 | 243 | 14.2% |
| Food and Beverage | $23,259 | 307 | 4.4% |
| Consulting Fee | $17,845 | 11 | 3.4% |
| Education | $197.56 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $182,189 | 222 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $66,285 | 114 | $0 (2024) |
| Travere Therapeutics, Inc. | $62,853 | 123 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $44,524 | 63 | $0 (2024) |
| Gilead Sciences, Inc. | $42,558 | 54 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $24,000 | 40 | $0 (2018) |
| Relypsa, Inc. | $22,834 | 44 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17,375 | 28 | $0 (2024) |
| Lilly USA, LLC | $17,279 | 24 | $0 (2024) |
| Vifor Pharma, Inc. | $9,754 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104,352 | 166 | Travere Therapeutics, Inc. ($38,266) |
| 2023 | $74,417 | 118 | Travere Therapeutics, Inc. ($23,002) |
| 2022 | $96,139 | 127 | Horizon Therapeutics plc ($35,254) |
| 2021 | $38,124 | 54 | Horizon Therapeutics plc ($26,344) |
| 2020 | $43,966 | 75 | Horizon Therapeutics plc ($28,154) |
| 2019 | $122,187 | 173 | Horizon Therapeutics plc ($71,278) |
| 2018 | $38,790 | 70 | Keryx Biopharmaceuticals, Inc. ($24,000) |
| 2017 | $7,514 | 21 | OPKO Pharmaceuticals, LLC ($3,520) |
All Payment Transactions
804 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $145.92 | General |
| Category: Nephrology | ||||||
| 12/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,480.00 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $545.00 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $494.93 | General |
| 12/05/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $22.25 | General |
| 12/05/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $21.00 | General |
| 12/05/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.87 | General |
| 12/02/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,480.00 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $745.00 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $520.42 | General |
| Category: DIABETES | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $773.04 | General |
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $102.31 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,480.00 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $545.00 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $707.23 | General |
| 11/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| 10/28/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: HBV | ||||||
| 10/28/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $379.77 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 268 | 729 | $180,340 | $113,606 |
| 2022 | 7 | 295 | 818 | $198,475 | $134,378 |
| 2021 | 9 | 328 | 891 | $211,300 | $146,700 |
| 2020 | 10 | 397 | 978 | $225,395 | $138,549 |
Total Patients
1,288
Total Services
3,416
Medicare Billing
$533,232
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 124 | $43,400 | $32,281 | 74.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 87 | 173 | $39,975 | $25,764 | 64.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 17 | 82 | $36,900 | $25,612 | 69.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 213 | $42,525 | $22,366 | 52.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $13,500 | $6,363 | 47.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 101 | $4,040 | $1,220 | 30.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 20 | 143 | $50,050 | $39,368 | 78.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 17 | 107 | $48,150 | $35,495 | 73.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 264 | $48,840 | $28,168 | 57.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 72 | 121 | $26,015 | $18,986 | 73.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 50 | 50 | $18,750 | $9,437 | 50.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 115 | $4,600 | $1,493 | 32.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 18 | $2,070 | $1,431 | 69.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 28 | 170 | $76,500 | $55,372 | 72.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 267 | $47,815 | $31,194 | 65.2% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 18 | 78 | $27,300 | $21,737 | 79.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 63 | 124 | $25,220 | $18,384 | 72.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 37 | 37 | $13,875 | $7,359 | 53.0% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 13 | 33 | $8,250 | $6,315 | 76.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 24 | 36 | $3,750 | $2,641 | 70.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 25 | $3,750 | $2,100 | 56.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 19 | 121 | $4,840 | $1,598 | 33.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 31 | 308 | $123,950 | $81,662 | 65.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 126 | 259 | $42,775 | $22,704 | 53.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 48 | 48 | $18,000 | $8,788 | 48.8% |
About Dr. Richard Chan, MD
Dr. Richard Chan, MD is a Nephrology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275506438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Chan, MD has received a total of $525,489 in payments from pharmaceutical and medical device companies, with $104,352 received in 2024. These payments were reported across 804 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($250,964).
As a Medicare-enrolled provider, Chan has provided services to 1,288 Medicare beneficiaries, totaling 3,416 services with total Medicare billing of $533,232. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location New York, NY
- Active Since 02/08/2006
- Last Updated 09/30/2014
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275506438
Products in Payments
- KRYSTEXXA (Biological) $188,827
- LOKELMA (Drug) $52,343
- Kerendia (Drug) $44,440
- Vemlidy (Drug) $41,992
- JARDIANCE (Drug) $32,979
- Veltassa (Drug) $29,491
- Auryxia (Drug) $24,000
- FARXIGA (Drug) $13,891
- AURYXIA (Drug) $9,227
- KRYSTEXXA (Drug) $5,779
- INVOKANA (Drug) $5,582
- Rayaldee (Drug) $3,520
- JYNARQUE (Drug) $2,858
- XARELTO (Drug) $371.53
- TARPEYO (Drug) $295.92
- ELIQUIS (Drug) $246.71
- STEGLATRO (Drug) $240.00
- Tavneos (Drug) $186.64
- XIA (Device) $154.80
- Vascepa (Drug) $144.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in New York
Dr. Gerald Appel, M.d, M.D
Nephrology — Payments: $842,842
Nephrology $842,842
Dr. Steven Coca, D.o., M.s, D.O., M.S
Nephrology — Payments: $388,012
Nephrology $388,012
Dr. Jai Radhakrishnan, M.d, M.D
Nephrology — Payments: $243,935
Nephrology $243,935
Dr. David Bernard, Md, MD
Nephrology — Payments: $235,726
Nephrology $235,726
Dr. Girish Nadkarni, Md, MD
Nephrology — Payments: $217,113
Nephrology $217,113
David Charytan, Md, MD
Nephrology — Payments: $180,512
Nephrology $180,512